Table 3. Curability assessment according to guideline-based criteria (n=5,374).

Curability status		Values
CR		4,325 (80.5)
	eCura A	4,076 (75.8)
	eCura B	249 (4.6)
L-NCR (eCura C-1)		150 (2.8)
S-NCR (eCura C-2)		899 (16.7)

Values are shown as number (%). Data are presented on a lesion basis. Each lesion was evaluated separately for curability, and patients with multiple gastric lesions were included in the analysis more than once. Rare histologic subtypes (e.g., gastric carcinoma with lymphoid stroma, fundic gland–type adenocarcinoma, mucinous adenocarcinoma, hepatoid adenocarcinoma, and micropapillary adenocarcinoma) were excluded from the curability analysis.

Components may not sum to totals due to rounding.

CR = curative resection; L-NCR = local non-curative resection; S-NCR = surgical non-curative resection.